This week, researchers published LIGO findings that hint at the existence of second-generation black holes. Astronomers captured a spectacular new image of the Milky Way across a wide range of radio ...

Debt Management: Agios Pharmaceuticals's debt-to-equity ratio is below the industry average. With a ratio of 0.04, the company relies less on debt financing, maintaining a healthier balance between ...

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...

Republicans, including President Donald Trump, had pushed voters to out the three justices as what has been a historically quiet race gained national attention.

Machine learning models are designed to take in data, to find patterns or relationships within those data, and to use what ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Threat actors refine tactics with DNS attacks, new RATs, and Rust-based malware. Stay ahead with this week’s top ThreatsDay ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...